SCHEMBL12546406

SCHEMBL12546406

Brc1ccc2c(c1)c1ccccc1n2-c1cccc(-c2ccc(-c3ccccc3)s2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ATM Q13315 1/20 0.44
▸ HSD17B1 P14061 2/20 0.39
▸ HSD17B2 P37059 2/20 0.39
▸ TSPO P30536 2/20 0.36
▸ KMT2A Q03164 4/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ RAD52 P43351 1/20 0.34
▸ DNM1 Q05193 1/20 0.34
▸ DCTPP1 Q9H773 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ NQO2 P16083 1/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ LIG1 P18858 1/20 0.32
▸ ABCG2 Q9UNQ0 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13134960 0.96 HSD17B1 (0.41) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL13134961 0.92 L3MBTL1 (0.36) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL12546432 0.91 L3MBTL1 (0.45) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL12362786 0.89 HSD17B1 (0.41) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL12546443 0.89 L3MBTL1 (0.55) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL30250575 0.88 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL14822296 0.88 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL29616363 0.88 L3MBTL1 (0.50) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL16605734 0.87 L3MBTL1 (0.48) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL20110427 0.87 L3MBTL1 (0.52) L3MBTL1KDM4EATMHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8968884-B2 Compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2015-03-03 — — US disclosed
US-8968884-B2 Compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2015-03-03 — — US disclosed
US-20110127495-A1 NEW COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2011-06-02 — — US disclosed
US-20110127495-A1 NEW COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2011-06-02 — — US disclosed
WO-2009061156-A1 NEW COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2009-05-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110127495-A1 NEW COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME PPOX, CYBA, CRY1 L3MBTL1 49/4885KDM4E 1981/4885ATM 2830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback